Next, as mentioned before, USP10 has not yet been shown either in vitro or in vivo to deubiquitinate SKP2 in BC specifically; so far, it has only been shown to deubiquitinate SKP2 in chronic myelogenous leukemia27. Here, USP10 is linked to breast cancer.